Riskpilot← Back to searchSign inGet full accessNeurovision Oy
OYActiveY-tunnus 0955508-8Karnaistenkatu 43-B28Ohjelmistojen suunnittelu ja valmistus · NACE 62010Est. 1994— employeeswww.neurovision.fi
Revenue 2023
EUR 72K
-82% vs 2022
EBITDA margin
47.9%
-42% vs 2022
Equity ratio
95.2%
Financial strength
Net profit 2023
EUR 31K
-28% vs 2022
| Revenue | EUR 72K | -82% |
| EBITDA | EUR 35K | -42% |
| Net profit | EUR 31K | -28% |
| Total assets | EUR 185K | -27% |
| Equity | EUR 177K | -22% |
| Employees | — | — |
Legal name
Neurovision Oy
Y-tunnus number
0955508-8
Legal form
Osakeyhtiö
NACE code
62010 · Ohjelmistojen suunnittelu ja valmistus
Founded
2. helmikuuta 1994
Share capital
EUR 6 728
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-01-31
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmies yksin
Company purpose
Tietotekniikan erityisalojen tutkimus, tuotekehitys, konsultointi, julkaisutoiminta ja jälleenmyynti ja arvopaperikauppa.
Address
Karnaistenkatu 43-B28
Phone
+358502731
Email
veli.lumme@neurovision.fi
Website
www.neurovision.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | 228 | 320 | 413 | 72 |
| Staff expenses | −11 | −42 | −23 | 12 |
| EBITDA | 35 | 39 | 60 | 35 |
| Depreciation & amort. | −10 | −7 | −5 | −4 |
| EBIT | 26 | 32 | 55 | 31 |
| Net financials | −1 | −0 | −1 | 0 |
| Profit before tax | 25 | 31 | 54 | 31 |
| Tax | 5 | 6 | 11 | −0 |
| Net profit | 20 | 25 | 43 | 31 |
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total assets | 228 | 240 | 255 | 185 |
| Equity | 179 | 194 | 228 | 177 |
| Long-term debt | 20 | 12 | 4 | 0 |
| Short-term debt | 29 | 34 | 23 | 9 |
| Total debt | 49 | 46 | 28 | 9 |
EBITDA margin
47.9%
This company
15.8%
Market median
+203% vs market
20202023
Equity ratio
95.2%
This company
38.2%
Market median
+149% vs market
20202023
Return on equity
17.6%
This company
18.4%
Market median
+4% vs market
20202023
Net profit margin
42.9%
This company
8.1%
Market median
+430% vs market
20202023
Asset turnover
0.39×
This company
1.12×
Market median
-65% vs market
20202023
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20202023
- Annual report 2023Filed via PRH / YTJ · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-02-01 – 2021-01-31
- Annual report 2020Filed via PRH / YTJ · Period 2019-02-01 – 2020-01-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
VE Liquidator | Liquidator | 2022 |
JA | Audit | 2018 |
PR Deputy auditor | Deputy auditor | 2018 |
AI Liquidator | Liquidator | 2022 |
| Former (1) | ||
AJ Deputy Member | Deputy Member | 2013 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2013 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Neurovision Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Veli Erkki Lumme | Liquidator | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Ari Juho Aleksi Lehtonen | Deputy Member | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |
| Antti Ilari Karhinen | Liquidator | 0 companies |
| Jari Tapani Järvinen | Board of Directors | 0 companies |